The Effect of Enteral Erythropoietin on Feeding Related Complications in Preterm Newborns

Not Applicable

• Conditions: Digestive System; Neonatal Diseases; Newborns with feeding intolerance and necrotizing enterocolitis

• Registration Number: PACTR201806003426116
• Lead Sponsor: Pediatric departement faculyty of medicine, Alexandria University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-05-29
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 72

Inclusion Criteria

preterm infants born ¿ 32 weeks gestation in a cardiovascular stable condition

Exclusion Criteria

infants who received chest compression or any medication given to the infant during resuscitation or any event suggesting exposure to hypoxia, infants with genetic syndromes, trisomies (13, 18...), inborn errors of metabolism (persistent metabolic acidosis, with history of multiple early sibling deaths or still births), infants with major congenital or acquired gastrointestinal tract malformation, infants with previous use of parenteral growth factors as: recombinant human erythropoietin & Granulocyte-macrophage colony-forming unit ( GM-CSF) and infants with previous use of intravenous immunoglobulin

Study & Design

• Study Type: Interventional
• Study Design: Not specified